Search Page

1

Cite

Share

In vivo and in vitro permeability in coeliac disease.

Vogelsang H, Schwarzenhofer M, Steiner B, Wyatt J, Oberhuber G. Vogelsang H, et al. Among authors: schwarzenhofer m. Aliment Pharmacol Ther. 2001 Sep;15(9):1417-25. doi: 10.1046/j.1365-2036.2001.01034.x. Aliment Pharmacol Ther. 2001. PMID: 11552914 Free article.

Cite

Share

2

Cite

Share

In vitro model of the pathogenesis of celiac disease.

Oberhuber G, Schwarzenhofer M, Vogelsang H. Oberhuber G, et al. Among authors: schwarzenhofer m. Dig Dis. 1998 Nov-Dec;16(6):341-4. doi: 10.1159/000016888. Dig Dis. 1998. PMID: 10207219 Review.

Cite

Share

3

Cite

Share

In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease.

Vogelsang H, Schwarzenhofer M, Granditsch G, Oberhuber G. Vogelsang H, et al. Among authors: schwarzenhofer m. Am J Gastroenterol. 1999 Apr;94(4):1057-61. doi: 10.1111/j.1572-0241.1999.01014.x. Am J Gastroenterol. 1999. PMID: 10201483

Cite

Share

4

Cite

Share

Changes in gastrointestinal permeability in celiac disease.

Vogelsang H, Schwarzenhofer M, Oberhuber G. Vogelsang H, et al. Among authors: schwarzenhofer m. Dig Dis. 1998 Nov-Dec;16(6):333-6. doi: 10.1159/000016886. Dig Dis. 1998. PMID: 10207217 Review.

Cite

Share

5

Cite

Share

Fat-soluble vitamins in patients with acute renal failure.

Druml W, Schwarzenhofer M, Apsner R, Hörl WH. Druml W, et al. Among authors: schwarzenhofer m. Miner Electrolyte Metab. 1998;24(4):220-6. doi: 10.1159/000057374. Miner Electrolyte Metab. 1998. PMID: 9554560

Cite

Share

6

Cite

Share

Impairment of citrate metabolism in acute hepatic failure.

Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, Kranz A. Apsner R, et al. Among authors: schwarzenhofer m. Wien Klin Wochenschr. 1997 Feb 28;109(4):123-7. Wien Klin Wochenschr. 1997. PMID: 9076929

Cite

Share

7

Cite

Share

Effect of two starting insulin regimens in patients with type II diabetes not controlled on a combination of oral antihyperglycemic medications.

Milicevic Z, Hancu N, Car N, Ivanyi T, Schwarzenhofer M, Jermendy G. Milicevic Z, et al. Among authors: schwarzenhofer m. Exp Clin Endocrinol Diabetes. 2009 May;117(5):223-9. doi: 10.1055/s-0028-1128126. Epub 2009 Mar 19. Exp Clin Endocrinol Diabetes. 2009. PMID: 19301232 Clinical Trial.

Cite

Share

8

Cite

Share

A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.

Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Ekangaki A, Levitt LK, Liong LH, Rais N, Tounsi H; Ramadan Study Group. Mattoo V, et al. Among authors: schwarzenhofer m. Diabetes Res Clin Pract. 2003 Feb;59(2):137-43. doi: 10.1016/s0168-8227(02)00202-4. Diabetes Res Clin Pract. 2003. PMID: 12560163 Clinical Trial.

Cite

Share

9

Cite

Share

The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.

Galic E, Vrtovec M, Bozikov V, Schwarzenhofer M, Milicevic Z. Galic E, et al. Among authors: schwarzenhofer m. Med Sci Monit. 2005 Dec;11(12):PI87-92. Epub 2005 Nov 24. Med Sci Monit. 2005. PMID: 16319804 Clinical Trial.

Cite

Share